Kepler Capital Markets set a €62.00 ($72.09) target price on Fresenius SE & Co KGaA (FRA:FRE) in a report issued on Monday morning. The brokerage currently has a buy rating on the stock.

Several other analysts have also commented on FRE. Societe Generale set a €72.00 ($83.72) price target on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Tuesday, November 13th. Credit Suisse Group set a €58.00 ($67.44) target price on Fresenius SE & Co KGaA and gave the company a neutral rating in a research report on Monday, November 19th. Berenberg Bank set a €81.85 ($95.17) target price on Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Friday, November 23rd. Deutsche Bank set a €75.00 ($87.21) target price on Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Monday, November 26th. Finally, HSBC set a €59.00 ($68.60) target price on Fresenius SE & Co KGaA and gave the company a neutral rating in a research report on Tuesday, December 4th. Ten analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The company presently has an average rating of Buy and an average target price of €60.71 ($70.59).

FRE stock opened at €49.11 ($57.10) on Monday. Fresenius SE & Co KGaA has a one year low of €60.16 ($69.95) and a one year high of €80.00 ($93.02).

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Featured Article: Options Trading

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.